Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
2,768 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00968396 | Ex-Vivo Depletion of Myeloma Cells From Peripheral Blood Progenitor Cell Grafts | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Apr 5, 2013 | clinicaltrials |
| NCT01340729 | Open-Label Study of TPI 287 for Patients With Metastatic Melanoma | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 5, 2013 | clinicaltrials |
| NCT01427205 |
| Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC) |
| withdrawn |
| Phase 2 |
| 0 |
| M.D. Anderson Cancer CenterOTHER |
| 0 |
| Apr 5, 2013 |
| clinicaltrials |
| NCT01508260 | Ultrafiltration (Aquapheresis) in Patients With Leukemia and Severe Fluid Overload | withdrawn | N/A | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Apr 5, 2013 | clinicaltrials |
| NCT01550900 | Prospective Trial of Metformin - Chemoprevention Role | withdrawn | N/A | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Apr 5, 2013 | clinicaltrials |
| NCT00038051 | Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies | completed | Phase 1 | 28 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 4, 2013 | clinicaltrials |
| NCT00429234 | Gemcitabine and Dasatinib in Advanced Solid Tumors | completed | Phase 1 | 54 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 4, 2013 | clinicaltrials |
| NCT01392144 | Phase II Evaluation of Exhaled Nitric Oxide (NO) | completed | — | 36 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 4, 2013 | clinicaltrials |
| NCT00338039 | Induction Cetuximab (IM-C225), Gemcitabine, and Oxaliplatin in Pancreatic Cancer Patients | completed | Phase 2 | 69 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 22, 2013 | clinicaltrials |
| NCT00410488 | Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI) | completed | N/A | 51 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 22, 2013 | clinicaltrials |
| NCT00490698 | Zoledronate With Atorvastatin in Renal Cell Carcinoma | completed | Phase 2 | 11 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 18, 2013 | clinicaltrials |
| NCT00412243 | Clofarabine and Cyclophosphamide Combination in Acute Lymphoblastic Leukemia Patients | completed | Phase 1 / Phase 2 | 51 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 12, 2013 | clinicaltrials |
| NCT00968071 | Decitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-risk Myelodysplastic Syndrome | completed | Phase 2 | 71 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 8, 2013 | clinicaltrials |
| NCT00398983 | Randomized Study of Decitabine in Maintenance Therapy of Acute Myeloid Leukemia (AML) | completed | Phase 2 / Phase 3 | 50 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 4, 2013 | clinicaltrials |
| NCT00429026 | Conditioning Regimen in Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation | terminated | Phase 2 | 40 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 4, 2013 | clinicaltrials |
| NCT00525603 | CFAR Study in Patients With Chronic Lymphocytic Leukemia | completed | Phase 2 | 60 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 4, 2013 | clinicaltrials |
| NCT00661544 | Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients | completed | Phase 1 / Phase 2 | 48 | M.D. Anderson Cancer CenterOTHER | 1 | Mar 4, 2013 | clinicaltrials |
| NCT00529022 | Azacitidine and Valproic Acid Plus Carboplatin in Patients With Ovarian Cancer | completed | Phase 1 | 36 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 20, 2013 | clinicaltrials |
| NCT00002463 | Combination Chemotherapy in Treating Children With Astrocytomas and Primitive Neuroectodermal Tumors | completed | Phase 2 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 18, 2013 | clinicaltrials |
| NCT01101412 | Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies | withdrawn | Phase 1 / Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Feb 15, 2013 | clinicaltrials |
| NCT00270907 | CT-2103 in Combination With Gemcitabine in Metastatic Breast Cancer | completed | Phase 1 | 13 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 13, 2013 | clinicaltrials |
| NCT00500422 | Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients | completed | Phase 1 | 134 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 13, 2013 | clinicaltrials |
| NCT00770731 | Study of Temsirolimus, Topotecan, and Bortezomib | completed | Phase 1 | 80 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 13, 2013 | clinicaltrials |
| NCT00428545 | Bevacizumab and Bortezomib in Patients With Advanced Malignancy | completed | Phase 1 | 104 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 12, 2013 | clinicaltrials |
| NCT00955812 | STAT3 Inhibitor for Solid Tumors | completed | Phase 1 | 24 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 12, 2013 | clinicaltrials |
| NCT01184534 | Multimedia Patient Education | completed | — | 50 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 12, 2013 | clinicaltrials |
| NCT00379353 | The Effects of Thalidomide on Symptom Clusters | completed | Phase 2 | 32 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 4, 2013 | clinicaltrials |
| NCT00500513 | Tracking of Respiratory-Induced Tumor Motion Using Implanted Fiducials | completed | N/A | 10 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 1, 2013 | clinicaltrials |
| NCT01404936 | Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease | completed | Phase 2 | 35 | M.D. Anderson Cancer CenterOTHER | 1 | Feb 1, 2013 | clinicaltrials |
| NCT00523809 | Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor | terminated | Phase 2 | 5 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 28, 2013 | clinicaltrials |
| NCT00684242 | Lenalidomide (Revlimid) for the Treatment of Refractory Cancer Pain | terminated | Phase 2 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 28, 2013 | clinicaltrials |
| NCT01540552 | Natural History of Lung Nodules Seen on CT Scans From Participants at High-Risk of Developing Lung Cancer | completed | — | 320 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 25, 2013 | clinicaltrials |
| NCT00601133 | Function and Balance for Inpatient Rehabilitation | completed | — | 24 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 10, 2013 | clinicaltrials |
| NCT00601744 | Social-Psychological Aspects of Orbital Exenteration | completed | — | 33 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 10, 2013 | clinicaltrials |
| NCT00491855 | Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis | completed | Phase 1 | 3 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 3, 2013 | clinicaltrials |
| NCT00509860 | Irinotecan (Camptosar) in Patients With Advanced Sarcomas | completed | Phase 2 | 38 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 3, 2013 | clinicaltrials |
| NCT00766220 | Yttrium Microspheres With Cetuximab Plus Irinotecan for Patients With Advanced Colorectal Cancer Mets to Liver | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Jan 3, 2013 | clinicaltrials |
| NCT00970996 | Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma(BCAA) | completed | Phase 1 | 10 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 3, 2013 | clinicaltrials |
| NCT00837993 | Ancillary Study GOG 158: Survival Analysis Based on Reclassification to a Two-Tier Grading System | completed | — | 241 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 21, 2012 | clinicaltrials |
| NCT00227656 | Capecitabine and Pegylated Interferon Alfa-2a in Treating Patients With Recurrent or Progressive Brain Metastases Due to Breast Cancer | terminated | Phase 2 | 2 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 11, 2012 | clinicaltrials |
| NCT00513357 | Melatonin Versus Placebo and the Effect on Appetite in Advanced Cancer Patients | completed | Phase 3 | 82 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 11, 2012 | clinicaltrials |
| NCT00424645 | Voraxaze for Delayed Methotrexate Clearance | terminated | Phase 1 / Phase 2 | 3 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 6, 2012 | clinicaltrials |
| NCT00429104 | Herceptin and GM-CSF for Metastatic Breast Cancer | completed | Phase 2 | 18 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 6, 2012 | clinicaltrials |
| NCT00527982 | Celecoxib as Adjuvant Biologic Therapy in Patients With Head and Neck and Lung Cancer | terminated | Phase 2 | 1 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 6, 2012 | clinicaltrials |
| NCT00541424 | Combined CT Colonography and PET Imaging in Mantle Cell Lymphoma | withdrawn | — | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Dec 6, 2012 | clinicaltrials |
| NCT00323557 | Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients | completed | Phase 2 | 39 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 5, 2012 | clinicaltrials |
| NCT00506064 | Melatonin Postoperative Sleep Study in Breast Cancer Patients | terminated | Phase 1 | 4 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 5, 2012 | clinicaltrials |
| NCT00790855 | Bendamustine in Acute Leukemia and MDS | terminated | Phase 1 / Phase 2 | 27 | M.D. Anderson Cancer CenterOTHER | 1 | Dec 4, 2012 | clinicaltrials |
| NCT01649622 | Bendamustine in Acute Lymphoblastic Leukemia/Lymphoma (ALL) | withdrawn | Phase 2 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Nov 8, 2012 | clinicaltrials |
| NCT00276523 | PEG-interferon Alfa-2b in Treating Patients With Stage II, Stage III, or Stage IV Head and Neck Cancer That Can Be Removed By Surgery | completed | Phase 2 | 3 | M.D. Anderson Cancer CenterOTHER | 1 | Oct 31, 2012 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials